{"id":357430,"date":"2026-11-20T10:58:42","date_gmt":"2026-11-20T05:28:42","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=357430"},"modified":"2026-11-20T10:58:42","modified_gmt":"2026-11-20T05:28:42","slug":"narayana-hrudayalaya-vs-kims-hospital-expansion","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/","title":{"rendered":"Narayana Hrudayalaya vs KIMS 2027: Similar Market Value, but a P\/E of 45 Against 164"},"content":{"rendered":"<div style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:10px 16px;margin:0 0 16px;\">\n<table style=\"width:100%;border-collapse:collapse;font-size:14px;\">\n<tr>\n<th style=\"text-align:left;padding:4px 10px;\">Narayana Hrudayalaya vs KIMS at a glance<\/th>\n<th style=\"text-align:left;padding:4px 10px;\">Narayana Hrudayalaya<\/th>\n<th style=\"text-align:left;padding:4px 10px;\">Krishna Institute of Medical Sciences<\/th>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>Share price (19 Nov 2026)<\/strong><\/td>\n<td style=\"padding:4px 10px;\">Rs 1,873.10<\/td>\n<td style=\"padding:4px 10px;\">Rs 767.80<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>Market cap<\/strong><\/td>\n<td style=\"padding:4px 10px;\">Rs 38,297 crore<\/td>\n<td style=\"padding:4px 10px;\">Rs 32,301 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>P\/E ratio<\/strong><\/td>\n<td style=\"padding:4px 10px;\">44.58<\/td>\n<td style=\"padding:4px 10px;\">163.98<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:4px 10px;\"><strong>Q2 FY27 net profit<\/strong><\/td>\n<td style=\"padding:4px 10px;\">Rs 301.1 crore<\/td>\n<td style=\"padding:4px 10px;\">Rs 74.6 crore<\/td>\n<\/tr>\n<\/table>\n<\/div>\n<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\">Narayana Hrudayalaya vs KIMS compares two fast-expanding Indian hospital chains that are close in market value but far apart on earnings. Narayana Hrudayalaya is valued at about Rs 38,297 crore and Krishna Institute of Medical Sciences (KIMS) at about Rs 32,301 crore. In Q2 FY27, Narayana&#8217;s revenue rose 73.6% and net profit 16.5% to Rs 301 crore, while KIMS&#8217;s revenue rose 41.3% and net profit 3.6% to Rs 75 crore. Narayana trades at a P\/E of 44.58 against 163.98 for KIMS.<\/p>\n<\/div>\n<p><strong>Narayana Hrudayalaya vs KIMS<\/strong> in 2027 is a lesson in how expansion affects valuation: the two chains have similar market values, but Narayana trades at <strong>44.58 times earnings<\/strong> while KIMS trades at <strong>163.98 times<\/strong>, because <strong>new hospitals<\/strong> have pushed KIMS&#8217;s profit down. The <strong>Narayana Hrudayalaya vs KIMS<\/strong> hospital expansion story explains most of the gap.<\/p>\n<p>Both stocks trade about 10.5% below their <strong>52-week highs<\/strong> and are measured within the broader <a href=\"https:\/\/univest.in\/indices\/nifty-500\/nifty-500-share-price-today\">Nifty 500<\/a>. This <strong>Narayana Hrudayalaya vs KIMS<\/strong> guide compares their business models, valuation, <strong>Q2 FY27 results<\/strong>, expansion plans, risks and shareholding.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=narayana-hrudayalaya-vs-kims-hospital-expansion\">Click Here &#8211; Get Free Investment Predictions<\/a><\/strong><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Narayana_Hrudayalaya_vs_KIMS_Company_Overview\" title=\"Narayana Hrudayalaya vs KIMS: Company Overview\">Narayana Hrudayalaya vs KIMS: Company Overview<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#What_Narayana_Hrudayalaya_Does\" title=\"What Narayana Hrudayalaya Does\">What Narayana Hrudayalaya Does<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#What_Krishna_Institute_of_Medical_Sciences_Does\" title=\"What Krishna Institute of Medical Sciences Does\">What Krishna Institute of Medical Sciences Does<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#How_Narayana_Hrudayalaya_and_KIMS_Make_Money\" title=\"How Narayana Hrudayalaya and KIMS Make Money\">How Narayana Hrudayalaya and KIMS Make Money<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Narayana_Hrudayalaya_vs_KIMS_Valuation_and_Key_Metrics\" title=\"Narayana Hrudayalaya vs KIMS Valuation and Key Metrics\">Narayana Hrudayalaya vs KIMS Valuation and Key Metrics<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Narayana_Hrudayalaya_vs_KIMS_Q2_FY27_Results\" title=\"Narayana Hrudayalaya vs KIMS Q2 FY27 Results\">Narayana Hrudayalaya vs KIMS Q2 FY27 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Narayana_Hrudayalaya_vs_KIMS_Hospital_Expansion_in_2027\" title=\"Narayana Hrudayalaya vs KIMS Hospital Expansion in 2027\">Narayana Hrudayalaya vs KIMS Hospital Expansion in 2027<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Narayana_scale_and_integration\" title=\"Narayana: scale and integration\">Narayana: scale and integration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#KIMS_new_hospitals_maturing\" title=\"KIMS: new hospitals maturing\">KIMS: new hospitals maturing<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Risks_in_Narayana_Hrudayalaya_vs_KIMS\" title=\"Risks in Narayana Hrudayalaya vs KIMS\">Risks in Narayana Hrudayalaya vs KIMS<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Risks_for_Narayana_Hrudayalaya\" title=\"Risks for Narayana Hrudayalaya\">Risks for Narayana Hrudayalaya<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Risks_for_Krishna_Institute_of_Medical_Sciences\" title=\"Risks for Krishna Institute of Medical Sciences\">Risks for Krishna Institute of Medical Sciences<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Narayana_Hrudayalaya_vs_KIMS_Shareholding\" title=\"Narayana Hrudayalaya vs KIMS Shareholding\">Narayana Hrudayalaya vs KIMS Shareholding<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Which_Investor_Does_Each_Hospital_Stock_Suit\" title=\"Which Investor Does Each Hospital Stock Suit?\">Which Investor Does Each Hospital Stock Suit?<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Narayana_Hrudayalaya_suits_investors_who_want_earnings-backed_growth\" title=\"Narayana Hrudayalaya suits investors who want earnings-backed growth\">Narayana Hrudayalaya suits investors who want earnings-backed growth<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#KIMS_suits_investors_betting_on_new_hospitals_maturing\" title=\"KIMS suits investors betting on new hospitals maturing\">KIMS suits investors betting on new hospitals maturing<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Final_View_on_Narayana_Hrudayalaya_vs_KIMS\" title=\"Final View on Narayana Hrudayalaya vs KIMS\">Final View on Narayana Hrudayalaya vs KIMS<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#FAQs_on_Narayana_Hrudayalaya_vs_KIMS\" title=\"FAQs on Narayana Hrudayalaya vs KIMS\">FAQs on Narayana Hrudayalaya vs KIMS<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Why_is_KIMSs_PE_so_much_higher_than_Narayanas\" title=\"Why is KIMS&#x27;s P\/E so much higher than Narayana&#x27;s?\">Why is KIMS&#x27;s P\/E so much higher than Narayana&#x27;s?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#How_did_Narayana_Hrudayalaya_perform_in_Q2_FY27\" title=\"How did Narayana Hrudayalaya perform in Q2 FY27?\">How did Narayana Hrudayalaya perform in Q2 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#How_did_KIMS_perform_in_Q2_FY27\" title=\"How did KIMS perform in Q2 FY27?\">How did KIMS perform in Q2 FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Which_hospital_chain_has_the_higher_ROE\" title=\"Which hospital chain has the higher ROE?\">Which hospital chain has the higher ROE?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Which_company_is_larger\" title=\"Which company is larger?\">Which company is larger?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-24\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#How_far_are_both_stocks_from_their_52-week_highs\" title=\"How far are both stocks from their 52-week highs?\">How far are both stocks from their 52-week highs?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-25\" href=\"https:\/\/univest.in\/blogs-2\/narayana-hrudayalaya-vs-kims-hospital-expansion\/#Is_Narayana_Hrudayalaya_vs_KIMS_a_buy_or_sell_decision\" title=\"Is Narayana Hrudayalaya vs KIMS a buy or sell decision?\">Is Narayana Hrudayalaya vs KIMS a buy or sell decision?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Narayana_Hrudayalaya_vs_KIMS_Company_Overview\"><\/span><strong>Narayana Hrudayalaya vs KIMS: Company Overview<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_Narayana_Hrudayalaya_Does\"><\/span><strong>What Narayana Hrudayalaya Does<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Narayana Hrudayalaya, founded by cardiac surgeon Dr Devi Shetty, runs a network of multi-speciality hospitals across India and a hospital in the Cayman Islands. It is known for high-volume, affordable tertiary care. Promoters hold 63.27%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_Krishna_Institute_of_Medical_Sciences_Does\"><\/span><strong>What Krishna Institute of Medical Sciences Does<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Krishna Institute of Medical Sciences (KIMS), based in Hyderabad, runs multi-speciality hospitals across Telangana and Andhra Pradesh and has been expanding into Maharashtra, Karnataka and Kerala. Promoters hold 32.66%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"How_Narayana_Hrudayalaya_and_KIMS_Make_Money\"><\/span><strong>How Narayana Hrudayalaya and KIMS Make Money<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Both earn from inpatient treatment, surgeries, outpatient care and diagnostics. Mature hospitals earn steady margins, while <strong>new hospitals<\/strong> usually lose money for a few years until occupancy builds up.<\/p>\n<p>Both are in expansion mode. Narayana&#8217;s revenue jump reflects a larger hospital base, including acquisitions, while KIMS has opened several <strong>new hospitals<\/strong> in new states, which is weighing on its profit.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Narayana_Hrudayalaya_vs_KIMS_Valuation_and_Key_Metrics\"><\/span><strong>Narayana Hrudayalaya vs KIMS Valuation and Key Metrics<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>These figures use the 19 November 2026 close and trailing twelve month ratios.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th>Narayana Hrudayalaya vs KIMS metric<\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/nh\/narayana-hrudayalaya-ltd-share-price-today\">Narayana Hrudayalaya<\/a><\/th>\n<th><a href=\"https:\/\/univest.in\/stocks\/kims\/krishna-institute-of-medical-sciences-ltd-share-price-today\">Krishna Institute of Medical Sciences<\/a><\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Share price (CMP)<\/td>\n<td>Rs 1,873.10<\/td>\n<td>Rs 767.80<\/td>\n<\/tr>\n<tr>\n<td>52-week high<\/td>\n<td>Rs 2,092.90<\/td>\n<td>Rs 858.00<\/td>\n<\/tr>\n<tr>\n<td>52-week low<\/td>\n<td>Rs 1,589.00<\/td>\n<td>Rs 575.80<\/td>\n<\/tr>\n<tr>\n<td>Distance from 52-week high<\/td>\n<td>-10.5%<\/td>\n<td>-10.5%<\/td>\n<\/tr>\n<tr>\n<td>Market capitalisation<\/td>\n<td>Rs 38,297 crore<\/td>\n<td>Rs 32,301 crore<\/td>\n<\/tr>\n<tr>\n<td>P\/E ratio (TTM)<\/td>\n<td>44.58<\/td>\n<td>163.98<\/td>\n<\/tr>\n<tr>\n<td>Industry P\/E<\/td>\n<td>63.67<\/td>\n<td>63.67<\/td>\n<\/tr>\n<tr>\n<td>P\/B ratio<\/td>\n<td>7.65<\/td>\n<td>8.22<\/td>\n<\/tr>\n<tr>\n<td>Return on equity (ROE)<\/td>\n<td>17.17%<\/td>\n<td>5.40%<\/td>\n<\/tr>\n<tr>\n<td>Debt to equity<\/td>\n<td>1.21<\/td>\n<td>0.90<\/td>\n<\/tr>\n<tr>\n<td>Dividend yield<\/td>\n<td>0.24%<\/td>\n<td>0.00%<\/td>\n<\/tr>\n<tr>\n<td>FY26 revenue<\/td>\n<td>Rs 7,996 crore<\/td>\n<td>Rs 3,931 crore<\/td>\n<\/tr>\n<tr>\n<td>FY26 net profit<\/td>\n<td>Rs 810.5 crore<\/td>\n<td>Rs 242.0 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The <strong>Narayana Hrudayalaya vs KIMS<\/strong> table shows Narayana trading at a <strong>P\/E of 44.58<\/strong> against 163.98 for KIMS. The hospital industry <strong>P\/E<\/strong> is 63.67, so Narayana trades below the sector and KIMS far above it.<\/p>\n<p>Narayana has a much higher <strong>return on equity<\/strong> at 17.17% against 5.40%. Both carry debt to fund expansion, with debt to equity of 1.21 for Narayana and 0.90 for KIMS.<\/p>\n<p>Both are about 10.5% below their <strong>52-week high<\/strong> levels. Narayana closed at Rs 1,873.10 against a high of Rs 2,092.90, and KIMS at Rs 767.80 against a high of Rs 858.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Narayana_Hrudayalaya_vs_KIMS_Q2_FY27_Results\"><\/span><strong>Narayana Hrudayalaya vs KIMS Q2 FY27 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Figures below are consolidated revenue and <strong>net profit<\/strong> for the quarter ended 30 September 2026.<\/p>\n<table style=\"width:100%;border-collapse:collapse;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th>Narayana Hrudayalaya vs KIMS Q2 FY27 (Sep 2026 quarter)<\/th>\n<th>Narayana Hrudayalaya<\/th>\n<th>Krishna Institute of Medical Sciences<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Revenue Q2 FY27<\/td>\n<td>Rs 2,896 crore<\/td>\n<td>Rs 1,363 crore<\/td>\n<\/tr>\n<tr>\n<td>Revenue Q2 FY26<\/td>\n<td>Rs 1,668 crore<\/td>\n<td>Rs 964.9 crore<\/td>\n<\/tr>\n<tr>\n<td>Revenue change YoY<\/td>\n<td>+73.6%<\/td>\n<td>+41.3%<\/td>\n<\/tr>\n<tr>\n<td>Net profit Q2 FY27<\/td>\n<td>Rs 301.1 crore<\/td>\n<td>Rs 74.6 crore<\/td>\n<\/tr>\n<tr>\n<td>Net profit Q2 FY26<\/td>\n<td>Rs 258.5 crore<\/td>\n<td>Rs 72.0 crore<\/td>\n<\/tr>\n<tr>\n<td>Net profit change YoY<\/td>\n<td>+16.5%<\/td>\n<td>+3.6%<\/td>\n<\/tr>\n<tr>\n<td>Net profit Q1 FY27<\/td>\n<td>Rs 207.3 crore<\/td>\n<td>Rs 37.4 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>In the <strong>Q2 FY27 results<\/strong>, Narayana&#8217;s revenue rose 73.6% to Rs 2,895.5 crore and <strong>net profit<\/strong> rose 16.5% to Rs 301.2 crore. Its <strong>operating margin<\/strong> eased to 21.2% from 25.9%, and profit grew from Rs 207.3 crore in the June quarter.<\/p>\n<p>KIMS&#8217;s revenue rose 41.3% to Rs 1,363 crore and <strong>net profit<\/strong> rose 3.6% to Rs 74.6 crore. Its <strong>operating margin<\/strong> held at 21.7%, and profit doubled from Rs 37.4 crore in Q1 FY27.<\/p>\n<p>In the quarter, both grew revenue far faster than profit, as new capacity added costs before earnings.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Narayana_Hrudayalaya_vs_KIMS_Hospital_Expansion_in_2027\"><\/span><strong>Narayana Hrudayalaya vs KIMS Hospital Expansion in 2027<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Narayana_scale_and_integration\"><\/span><strong>Narayana: scale and integration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Narayana&#8217;s FY26 revenue rose 43.4% to Rs 7,996 crore while <strong>net profit<\/strong> rose 2.6% to Rs 810.5 crore. Integrating its expanded network and lifting margins back toward earlier levels is its main task for 2027.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"KIMS_new_hospitals_maturing\"><\/span><strong>KIMS: new hospitals maturing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>KIMS&#8217;s FY26 revenue rose 28.2% to Rs 3,931 crore, but net profit fell 41.7% to Rs 242 crore as new hospitals added costs. As these hospitals fill up, profit could recover sharply, which is what its high <strong>P\/E<\/strong> is pricing in.<\/p>\n<p>In the <strong>Narayana Hrudayalaya vs KIMS<\/strong> hospital expansion race, KIMS carries more near-term execution risk, while Narayana has the stronger current earnings base.<\/p>\n<p style=\"margin-top:24px;\"><strong><a href=\"https:\/\/univest.in\/screeners\">Compare hospital stocks on the Univest Screener<\/a><\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Risks_in_Narayana_Hrudayalaya_vs_KIMS\"><\/span><strong>Risks in Narayana Hrudayalaya vs KIMS<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Risks_for_Narayana_Hrudayalaya\"><\/span><strong>Risks for Narayana Hrudayalaya<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Narayana&#8217;s main risks are integrating acquired hospitals, margin pressure and higher debt. Foreign institutions cut their stake from 10.49% to 9.01%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Risks_for_Krishna_Institute_of_Medical_Sciences\"><\/span><strong>Risks for Krishna Institute of Medical Sciences<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>In the <strong>Narayana Hrudayalaya vs KIMS<\/strong> risk check, KIMS&#8217;s main risk is that new hospitals take longer to break even. A <strong>P\/E<\/strong> of 163.98 leaves very little room for delays. Promoters trimmed their stake from 34.11% to 32.66%.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Narayana_Hrudayalaya_vs_KIMS_Shareholding\"><\/span><strong>Narayana Hrudayalaya vs KIMS Shareholding<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;\" border=\"1\" cellpadding=\"8\">\n<thead>\n<tr>\n<th>Narayana Hrudayalaya vs KIMS shareholding (Sep &#8217;26, change vs Sep &#8217;25)<\/th>\n<th>Narayana Hrudayalaya<\/th>\n<th>Krishna Institute of Medical Sciences<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>Promoters<\/td>\n<td>63.27% (-0.58 pts)<\/td>\n<td>32.66% (-1.45 pts)<\/td>\n<\/tr>\n<tr>\n<td>Foreign institutions (FII)<\/td>\n<td>9.01% (-1.48 pts)<\/td>\n<td>15.01% (-0.02 pts)<\/td>\n<\/tr>\n<tr>\n<td>Domestic institutions (DII)<\/td>\n<td>10.68% (+2.92 pts)<\/td>\n<td>32.30% (+0.18 pts)<\/td>\n<\/tr>\n<tr>\n<td>Public and others<\/td>\n<td>17.04% (-0.86 pts)<\/td>\n<td>20.03% (+1.29 pts)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Narayana promoters hold 63.27%. Domestic institutions raised their stake from 7.76% to 10.68%.<\/p>\n<p>KIMS promoters hold 32.66%. Domestic institutions hold 32.30% and foreign institutions 15.01%, both little changed. KIMS has a much larger institutional base.<\/p>\n<p style=\"margin-top:24px;\"><strong>Download the <a href=\"https:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"https:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Narayana Hrudayalaya and KIMS live and follow healthcare research.<\/strong><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Which_Investor_Does_Each_Hospital_Stock_Suit\"><\/span><strong>Which Investor Does Each Hospital Stock Suit?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Narayana_Hrudayalaya_suits_investors_who_want_earnings-backed_growth\"><\/span><strong>Narayana Hrudayalaya suits investors who want earnings-backed growth<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Within <strong>Narayana Hrudayalaya vs KIMS<\/strong>, Narayana fits investors who want a hospital chain with a P\/E below the sector and an ROE above 17%. They need to accept integration and debt risks.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"KIMS_suits_investors_betting_on_new_hospitals_maturing\"><\/span><strong>KIMS suits investors betting on new hospitals maturing<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>KIMS fits investors who expect its new hospitals to drive a sharp profit recovery. They need to accept a very high P\/E today.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Final_View_on_Narayana_Hrudayalaya_vs_KIMS\"><\/span><strong>Final View on Narayana Hrudayalaya vs KIMS<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Narayana Hrudayalaya vs KIMS<\/strong> pairs two expanding hospital chains with similar market values. Narayana earns more, with an ROE of 17.17% and a P\/E of 44.58. KIMS&#8217;s profit is depressed by new hospitals, which leaves it at 163.98 times earnings.<\/p>\n<p>The <strong>Narayana Hrudayalaya vs KIMS<\/strong> outlook for 2027 depends on how quickly new capacity turns profitable. Occupancy and margins are the numbers to watch.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are drawn from publicly available information and company disclosures, and they may change after publication. Please verify all data independently before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"FAQs_on_Narayana_Hrudayalaya_vs_KIMS\"><\/span><strong>FAQs on Narayana Hrudayalaya vs KIMS<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_KIMSs_PE_so_much_higher_than_Narayanas\"><\/span><strong>Why is KIMS&#x27;s P\/E so much higher than Narayana&#x27;s?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> KIMS trades at a P\/E of 163.98, compared with 44.58 for Narayana Hrudayalaya. KIMS&#x27;s FY26 profit fell 41.7% to Rs 242 crore as new hospitals added costs. The market expects profit to recover as these hospitals mature. The hospital industry P\/E is 63.67.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_Narayana_Hrudayalaya_perform_in_Q2_FY27\"><\/span><strong>How did Narayana Hrudayalaya perform in Q2 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Narayana&#x27;s revenue rose 73.6% to Rs 2,895.5 crore and net profit rose 16.5% to Rs 301.2 crore in Q2 FY27. Its operating margin eased to 21.2% from 25.9%. Profit grew from Rs 207.3 crore in the June quarter. A larger hospital base drove revenue growth.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_did_KIMS_perform_in_Q2_FY27\"><\/span><strong>How did KIMS perform in Q2 FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> KIMS&#x27;s revenue rose 41.3% to Rs 1,363 crore and net profit rose 3.6% to Rs 74.6 crore in Q2 FY27. Its operating margin was 21.7%. Profit doubled from Rs 37.4 crore in the June quarter. New hospitals continue to weigh on earnings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_hospital_chain_has_the_higher_ROE\"><\/span><strong>Which hospital chain has the higher ROE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Narayana Hrudayalaya has a return on equity of 17.17%, compared with 5.40% for KIMS. Narayana&#x27;s mature hospitals earn steady returns. KIMS&#x27;s ROE is low because of new hospital costs. Both companies carry debt for expansion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_company_is_larger\"><\/span><strong>Which company is larger?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Narayana Hrudayalaya has a market cap of about Rs 38,297 crore, compared with Rs 32,301 crore for KIMS. Narayana&#x27;s FY26 revenue was Rs 7,996 crore against Rs 3,931 crore for KIMS. Narayana&#x27;s FY26 net profit was Rs 810.5 crore and KIMS&#x27;s was Rs 242 crore. Their market values are closer than their earnings.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_far_are_both_stocks_from_their_52-week_highs\"><\/span><strong>How far are both stocks from their 52-week highs?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Narayana closed at Rs 1,873.10 on 19 November 2026, about 10.5% below its 52-week high of Rs 2,092.90. KIMS closed at Rs 767.80, also about 10.5% below its high of Rs 858. Narayana&#x27;s 52-week low is Rs 1,589 and KIMS&#x27;s is Rs 575.80. Prices change daily.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Narayana_Hrudayalaya_vs_KIMS_a_buy_or_sell_decision\"><\/span><strong>Is Narayana Hrudayalaya vs KIMS a buy or sell decision?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> This Narayana Hrudayalaya vs KIMS comparison is educational and does not give a buy or sell call. Narayana offers earnings-backed growth at a lower P\/E, while KIMS offers a recovery case at a very high P\/E. Both carry expansion risk. Investors should consult a SEBI-registered adviser before acting.<\/p>\n<div class=\"faq-schema\"><script type=\"application\/ld+json\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"Why is KIMS's P\/E so much higher than Narayana's?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"KIMS trades at a P\/E of 163.98, compared with 44.58 for Narayana Hrudayalaya. KIMS's FY26 profit fell 41.7% to Rs 242 crore as new hospitals added costs. The market expects profit to recover as these hospitals mature. The hospital industry P\/E is 63.67.\"}},{\"@type\":\"Question\",\"name\":\"How did Narayana Hrudayalaya perform in Q2 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Narayana's revenue rose 73.6% to Rs 2,895.5 crore and net profit rose 16.5% to Rs 301.2 crore in Q2 FY27. Its operating margin eased to 21.2% from 25.9%. Profit grew from Rs 207.3 crore in the June quarter. A larger hospital base drove revenue growth.\"}},{\"@type\":\"Question\",\"name\":\"How did KIMS perform in Q2 FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"KIMS's revenue rose 41.3% to Rs 1,363 crore and net profit rose 3.6% to Rs 74.6 crore in Q2 FY27. Its operating margin was 21.7%. Profit doubled from Rs 37.4 crore in the June quarter. New hospitals continue to weigh on earnings.\"}},{\"@type\":\"Question\",\"name\":\"Which hospital chain has the higher ROE?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Narayana Hrudayalaya has a return on equity of 17.17%, compared with 5.40% for KIMS. Narayana's mature hospitals earn steady returns. KIMS's ROE is low because of new hospital costs. Both companies carry debt for expansion.\"}},{\"@type\":\"Question\",\"name\":\"Which company is larger?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Narayana Hrudayalaya has a market cap of about Rs 38,297 crore, compared with Rs 32,301 crore for KIMS. Narayana's FY26 revenue was Rs 7,996 crore against Rs 3,931 crore for KIMS. Narayana's FY26 net profit was Rs 810.5 crore and KIMS's was Rs 242 crore. Their market values are closer than their earnings.\"}},{\"@type\":\"Question\",\"name\":\"How far are both stocks from their 52-week highs?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Narayana closed at Rs 1,873.10 on 19 November 2026, about 10.5% below its 52-week high of Rs 2,092.90. KIMS closed at Rs 767.80, also about 10.5% below its high of Rs 858. Narayana's 52-week low is Rs 1,589 and KIMS's is Rs 575.80. Prices change daily.\"}},{\"@type\":\"Question\",\"name\":\"Is Narayana Hrudayalaya vs KIMS a buy or sell decision?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"This Narayana Hrudayalaya vs KIMS comparison is educational and does not give a buy or sell call. Narayana offers earnings-backed growth at a lower P\/E, while KIMS offers a recovery case at a very high P\/E. Both carry expansion risk. Investors should consult a SEBI-registered adviser before acting.\"}}]}<\/script><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Narayana Hrudayalaya vs KIMS 2027: the two hospital chains are close in market value, but Narayana trades at 44.58 times earnings with a 17.17% ROE, while KIMS trades at 163.98 times with a 5.40% ROE. A data-led comparison.<\/p>\n","protected":false},"author":35,"featured_media":357429,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[24],"tags":[24444,7594,14767,7040,18947],"class_list":["post-357430","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-market","tag-24444","tag-hospitals","tag-krishna-institute-of-medical-sciences","tag-narayana-hrudayalaya","tag-stock-comparison"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["357429"],"rank_math_title":["Narayana Hrudayalaya vs KIMS 2027: Hospital Stocks Compared"],"rank_math_description":["Narayana Hrudayalaya vs KIMS 2027: hospital expansion, Q2 FY27 results, P\/E, ROE, margins, shareholding and share price of two hospital chains compared."],"rank_math_focus_keyword":["Narayana Hrudayalaya vs KIMS"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/narayana-hrudayalaya-vs-kims-2027-similar-market-value-but-a-p-e-of-45-against.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/357430","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/35"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=357430"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/357430\/revisions"}],"predecessor-version":[{"id":357431,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/357430\/revisions\/357431"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/357429"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=357430"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=357430"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=357430"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}